FDA Head & Former ExL Speaker, Dr. Scott Gottlieb, Takes to Twitter With Clear Stance on Vaccines
Monday July 24th, 2017
Recently sworn-in commissioner of the Food and Drug Administration (FDA) Dr. Scott Gottlieb has affirmed his stance on the vaccination debate in many instances, but a recent Twitter post is sure to make his intentions on the matter perfectly clear. Unlike the man who appointed him to his position, President Donald Trump, toes the line of anti-vaccine and pro-vaccine, Gottlieb is embracing his new status to spread scientific data and other newsworthy tidbits on the matter.
In a message to his followers, Dr. Gottlieb shared an infographic the country before and after the development and administration of vaccines. The staggering information, which isn’t new in any way, is delivered in an easy-to-understand graphic that makes it abundantly clear on where Gottlieb stands in regards to this subject. Check out his tweet right here:
How Vaccines Have Altered U.S. Health, Summarized in One Graphic. Data Courtesy of @CDCgov Graphic Courtesy of Leon Farrant #vaccineswork pic.twitter.com/nvVYotuLC8
— Scott Gottlieb, M.D. (@SGottliebFDA) July 23, 2017
Gottlieb has also been vocal about the opioid crisis, increasing generics on the market, drug pricing, and more in the first few months in his position. If you’re interested in topics like this, we recommend looking into our 4th Human Abuse Liability & Abuse-Deterrent Formulations conference in Bethesda, MD, on November 6–7, 2017. It is the leading industry event for overcoming technical, clinical, and marketplace challenged involved in reducing the potential for prescription drug abuse — arguably one of the biggest issues of the FDA under Dr. Gottlieb’s commission. Discover our impressive agenda, esteemed speaking faculty, and simple registration process over at the official website of the conference: HERE!
Get Involved:
To share your expertise on the speaking faculty, contact Matthew Greenbaum, Production Team Leader, at 212.400.6242 or mgreenbaum@exlevents.com.
If you are interested in sponsorship or exhibition opportunities, please contact Eric Morrin, Senior Business Development Manager, at 212-400-6228 or emorrin@exlevents.com.
From The Blog
- Clinical
- Commercial Strategy
- Communications
- Compliance
- Content Marketing
- Data Management
- Digital Marketing
- Drug Safety
- Emerging Markets
- ExL Events News
- Financial
- Healthcare
- Marketing
- Medical Devices
- Medical Education
- Meeting Planning
- Patient Engagement
- Pharmaceutical
- Preclinical/R&D
- Public/Government Relations
- Quality
- Regulatory Affairs
- Technology
Featured Partners
Kelly Willenberg LLC is a full service research compliance organization serving clients on improving operations. She employs technologies to improve operational aspects of compliance based on client needs. She assists in the implementation of billing compliance programs, offers training seminars, builds coverage analysis and helps with process improvement. She can also assist with process improvement, quality assurance and assessing vulnerabilities in all aspects of research compliance.
Read more.
FiercePharma is a digital media publication, reporting and delivering daily news and objective analysis for business professionals in global industries. FiercePharma offers broad coverage serving a wide range of specific functional interests, including manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline; and the influence of big data, executive moves and social media on it all.